Attached files
| file | filename |
|---|---|
| 10-Q/A - Nuo Therapeutics, Inc. | v207314_10qa.htm |
| EX-32.2 - Nuo Therapeutics, Inc. | v207314_ex32-2.htm |
| EX-31.1 - Nuo Therapeutics, Inc. | v207314_ex31-1.htm |
| EX-31.2 - Nuo Therapeutics, Inc. | v207314_ex31-2.htm |
Exhibit
32.1
CERTIFICATION
OF CHIEF EXECUTIVE OFFICER
PURSUANT
TO 18 U.S.C. §1350
Pursuant
to 18 U.S.C. §1350 and in connection with the Quarterly Report on Form 10-Q/A of
Cytomedix, Inc. (the “Company”) for the fiscal period ended September 30, 2010
(the “Report”), I, Martin P. Rosendale, Chief Executive Officer of the Company,
hereby certify that to the best of my knowledge and belief:
|
1.
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
2.
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company
for said period.
|
|
/s/ Martin P. Rosendale
|
||
|
Martin
P. Rosendale
|
||
|
Chief
Executive Officer
|
||
|
Date: January
7, 2011
|
A
signed original of this written statement has been provided to Cytomedix, Inc.
and will be retained by Cytomedix, Inc. and furnished to the Securities and
Exchange Commission or its staff upon request.